EMD revenue jumps 191% year-over-year to $4.05M
EMD reported revenue up 191% year-over-year to $4.05M, alongside sharp increases in operational clinics and patients treated, as it cites funding agreements and regulatory tailwinds to support expansion and drug development.
05M, with operational clinics and patients treated increasing sharply. Major funding agreements and regulatory tailwinds are supporting continued expansion and drug development, as the company focuses on higher clinic utilisation and international growth.